ÈËÆÞÖгöÊÓƵ

Skip to main content
Ben Shofty
( out of 42 reviews )

Ben Shofty, MD, PhD

Languages spoken: English, Hebrew, Spanish

Clinical Locations

Clinical Neurosciences Center

Salt Lake City
801-585-7575
  • Ben Shofty, MD/PhD is an Israeli-board certified functional neurosurgeon and a former Israeli national rugby player. He graduated from the Tel-Aviv ÈËÆÞÖгöÊÓƵ Faculty of Medicine, and received a PhD in systems neuroscience from the Israeli Institute of Technology. He completed his neurosurgical training at the Tel-Aviv Medical Center, followed by two years of combined research/clinical fellowship at Baylor College of Medicine. His practice will focus on neuromodulation for psychiatric disorders, surgical treatments for cancer pain, movement disorders and epilepsy. In his lab, he is investigating high-order cognition and network dependent functions such as creativity and mind wondering, as well as novel interventions for OCD, depression and PTSD. In addition, he is interested in advanced imaging and visual biopsies.

    Board Certification

    Board of Neurosurgery (Israel)
    Educational Commission for Foreign Medical Graduates

    Patient Rating

    4.9 /5
    ( out of 42 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 16, 2024
    CLINICAL NEUROSCIENCES CENTER

    He took the time to explain what was going on with my disease and how to take care of it moving forward. I really appreciated the time he took with us.

    September 16, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Shofty is friendly and personable. He takes whatever time is needed to fully explain and answer questions. At the start of the visit, I was very stressed. He quickly picked up on this, addressed my concerns, easing my anxiety and stress. We discussed realistic expectations of the upcoming procedure. He provided information on how to contact him and his office and encouraged me to make use of the contact information. Both he and his nurse, Alison, alleviated my fears and elicited confidence in them as practitioners. I am confident that my upcoming surgery will go well.

    September 15, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr Shofty has a calm, confident demeanor which eased my concerns about the procedure. He answered any questions I had and supplied information in a proactive way, providing information that I had not considered asking about. And it appears that he can perform as well as explain because I'm extremely satisfied with the results.

    September 01, 2024
    CLINICAL NEUROSCIENCES CENTER

    Great personable doctor and did a great job with a very complex surgery.

    July 13, 2024
    CLINICAL NEUROSCIENCES CENTER

    Great MD, very skilled and knowledgeable.

    June 23, 2024
    CLINICAL NEUROSCIENCES CENTER

    I loved my entire experience. I have nothing even remotely bad to say.

    May 19, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr Shofty is amazing. He listened to me because I had some concerns and he was able to address everything and assured me that this will be an easy operation. Thank you doctor

    May 04, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Ben Shofty has a marvelous presence about him. And, he does not have that attitude of so many in the medical field that leaves us clients wondering: what's really ahead. Dr. Shofty was gracious, kind, and very ¿open¿ about everything. It's honestly a pleasure to have met with Dr. Ben. I'm truly looking forward, now, to this coming experience. Most grateful, I and my dear wife, Susan, are!!! Thank You, Dr. Shofty.

    April 21, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Ben Shofty is one of the finest people we've met in the medical field. He took the time to make sure we understood the upcoming procedure for our son and urged us to ask questions and express concerns. He's amazing.

  • Ben Shofty, MD/PhD is an Israeli-board certified functional neurosurgeon and a former Israeli national rugby player. He graduated from the Tel-Aviv ÈËÆÞÖгöÊÓƵ Faculty of Medicine, and received a PhD in systems neuroscience from the Israeli Institute of Technology. He completed his neurosurgical training at the Tel-Aviv Medical Center, followed by two years of combined research/clinical fellowship at Baylor College of Medicine. His practice will focus on neuromodulation for psychiatric disorders, surgical treatments for cancer pain, movement disorders and epilepsy. In his lab, he is investigating high-order cognition and network dependent functions such as creativity and mind wondering, as well as novel interventions for OCD, depression and PTSD. In addition, he is interested in advanced imaging and visual biopsies.

    Board Certification and Academic Information

    Academic Departments Neurosurgery -Primary
    Board Certification
    Board of Neurosurgery (Israel)
    Educational Commission for Foreign Medical Graduates

    Education history

    Fellowship Stereotactic and Functional Neurosurgery - Baylor College of Medicine Fellow
    Neurosurgery - Tel Aviv ÈËÆÞÖгöÊÓƵ Sackler Faculty of Medicine Chief Resident
    Residency Neurosurgery - Tel Aviv ÈËÆÞÖгöÊÓƵ Sackler Faculty of Medicine Resident
    Systems Neuroscience - Technion - Israeli Institute of Technology Ph.D.
    Internship Rotating - Rambam ÈËÆÞÖгöÊÓƵ Care Campus Intern
    Medicine - Tel Aviv ÈËÆÞÖгöÊÓƵ Sackler Faculty of Medicine M.D.
    Professional Medical Medical Science (Pre-Med) - Tel Aviv ÈËÆÞÖгöÊÓƵ Sackler Faculty of Medicine B.Med.Sci.

    Selected Publications

    Journal Article

    1. Bartoli E, Devara E, Dang HQ, Rabinovich R, Mathura RK, Anand A, Pascuzzi BR, Adkinson J, Kenett YN, Bijanki KR, Sheth SA, Shofty B (2024). Default mode network electrophysiological dynamics and causal role in creative thinking. Brain, 147(10), 3409-3425. ()
    2. Provenza NR, Reddy S, Allam AK, Rajesh SV, Diab N, Reyes G, Caston RM, Katlowitz KA, Gandhi AD, Bechtold RA, Dang HQ, Najera RA, Giridharan N, Kabotyanski KE, Momin F, Hasen M, Banks GP, Mickey BJ, Kious BM, Shofty B, Hayden BY, Herron JA, Storch EA, Patel AB, Goodman WK, Sheth SA (2024). Disruption of neural periodicity predicts clinical response after deep brain stimulation for obsessive-compulsive disorder. Nat Med, 30(10), 3004-3014. ()
    3. Bergman L, Shofty B, Agur A, Sibony SU, Treiber JM, Curry DJ, Fried I, Weiner HL, Roth J (2024). Hippocampal resection during hemispherotomy: is it needed? Childs Nerv Syst. ()
    4. Findlay MC, Tenhoeve SA, Campbell JM, Yost S, Gautam D, Rahimpour S, Botros D, Liang AS, Alshaikh JT, Kassavetis P, Moretti P, Embree LM, Shofty B (2024). Radiographic abnormalities and their clinical significance in patients with Parkinson disease who receive deep brain stimulation implants. J Neurosurg, 1-8. ()
    5. Xiao J, Adkinson JA, Myers J, Allawala AB, Mathura RK, Pirtle V, Najera R, Provenza NR, Bartoli E, Watrous AJ, Oswalt D, Gadot R, Anand A, Shofty B, Mathew SJ, Goodman WK, Pouratian N, Pitkow X, Bijanki KR, Hayden B, Sheth SA (2024). Beta activity in human anterior cingulate cortex mediates reward biases. Nat Commun, 15(1), 5528. ()
    6. Gadot R, Li N, Shofty B, Avendano-Ortega M, McKay S, Bijanki KR, Robinson ME, Banks G, Provenza N, Storch EA, Goodman WK, Horn A, Sheth SA (2023). Tractography-Based Modeling Explains Treatment Outcomes in Patients Undergoing Deep Brain Stimulation for Obsessive-Compulsive Disorder. Biol Psychiatry, 96(2), 95-100. ()
    7. Venkatraman V, Futch BG, Bode Padron KJ, Yang LZ, Lee HJ, Seas A, Parente B, Shofty B, Lad SP, Williamson TL, Rahimpour S (2024). Disparities in the treatment of movement disorders using deep brain stimulation. J Neurosurg, 141(1), 241-251. ()
    8. Venkatraman V, Futch BG, Bartlett A, Yang LZ, Lee HJ, Shofty B, Parente BA, Lad SP, Williamson TL, Rahimpour S (2023). Disparities in Access to Deep Brain Stimulation and Responsive Neurostimulation Approaches to Drug-Resistant Epilepsy. Neuromodulation, 27(4), 792-799. ()
    9. Campbell JM, Yost S, Gautam D, Herich A, Botros D, Slaughter M, Chodakiewitz M, Arain A, Peters A, Richards S, Newman B, Johnson B, Rahimpour S, Shofty B (2024). Delays in the diagnosis and surgical treatment of drug-resistant epilepsy: A cohort study. Epilepsia, 65(5), 1314-1321. ()
    10. Gautam D, Venkatraman V, Horns J, Yang LZ, Lee HJ, Kassavetis P, Alshaikh J, Moretti P, Shofty B, Rahimpour S (2024). Demographics of focused ultrasound thalamotomy for essential tremor and trends in deep brain stimulation surgery after its introduction in the USA. BMJ Neurol Open, 6(1), e000582. ()
    11. Allawala A, Bijanki KR, Oswalt D, Mathura RK, Adkinson J, Pirtle V, Shofty B, Robinson M, Harrison MT, Mathew SJ, Goodman WK, Pouratian N, Sheth SA, Borton DA (2024). Prefrontal network engagement by deep brain stimulation in limbic hubs. Front Hum Neurosci, 17, 1291315. ()
    12. Gabay S, Sapir Y, Korn A, Hochberg U, Tellem R, Zegerman A, Brogan SE, Rahimpour S, Shofty B, Strauss I (2023). Optimization of Radiofrequency Needle Placement in Percutaneous Cordotomy Using Electromyography in the Deeply Sedated Patient. Oper Neurosurg (Hagerstown), 26(1), 22-27. ()
    13. Roth J, Bergman L, Weil AG, Brunette-Clement T, Weiner HL, Treiber JM, Shofty B, Cukiert A, Cukiert CM, Tripathi M, Sarat Chandra P, Bollo RJ, Machado HR, Santos MV, Gaillard WD, Oluigbo CO, Ibrahim GM, Jallo GI, Shimony N, ONeill BR, Budke M, Prez-Jimnez M, Mangano FT, Iwasaki M, Iijima K, Gonzalez-Martinez J, Kawai K, Ishishita Y, Elbabaa SK, Bello-Espinosa L, Fallah A, Maniquis CAB, Ben-Zvi I, Tisdall M, Panigrahi M, Jayalakshmi S, Blount JP, Dorfmller G, Bulteau C, Stone SS, Bolton J, Uliel-Sibony S (2023). Added value of corpus callosotomy following vagus nerve stimulation in ÈËÆÞÖгöÊÓƵren with Lennox-Gastaut syndrome: A multicenter, multinational study. Epilepsia. ()
    14. Shofty B, Gadot R, Viswanathan A, Provenza NR, Storch EA, McKay SA, Meyers MS, Hertz AG, Avendano-Ortega M, Goodman WK, Sheth SA (2022). Intraoperative valence testing to adjudicate between ventral capsule/ventral striatum and bed nucleus of the stria terminalis target selection in deep brain stimulation for obsessive-compulsive disorder. J Neurosurg, 139(2), 442-450. ()
    15. Metzger BA, Kalva P, Mocchi MM, Cui B, Adkinson JA, Wang Z, Mathura R, Kanja K, Gavvala J, Krishnan V, Lin L, Maheshwari A, Shofty B, Magnotti JF, Willie JT, Sheth SA, Bijanki KR (2023). Intracranial stimulation and EEG feature analysis reveal affective salience network specialization. Brain, 146(10), 4366-4377. ()
    16. Xiao J, Provenza NR, Asfouri J, Myers J, Mathura RK, Metzger B, Adkinson JA, Allawala AB, Pirtle V, Oswalt D, Shofty B, Robinson ME, Mathew SJ, Goodman WK, Pouratian N, Schrater PR, Patel AB, Tolias AS, Bijanki KR, Pitkow X, Sheth SA (2023). Decoding Depression Severity From Intracranial Neural Activity. Biol Psychiatry. ()
    17. Jalon I, Berger A, Shofty B, Goldway N, Artzi M, Gurevitch G, Hochberg U, Tellem R, Hendler T, Gonen T, Strauss I (2022). Lesions to both somatic and affective pain pathways lead to decreased salience network connectivity. Brain. ()
    18. Giridharan N, Katlowitz KA, Anand A, Gadot R, Najera RA, Shofty B, Snyder R, Larrinaga C, Prablek M, Karas PJ, Viswanathan A, Sheth SA (2022). Robot-Assisted Deep Brain Stimulation: High Accuracy and Streamlined Workflow. Oper Neurosurg (Hagerstown), 23(3), 254-260. ()
    19. Gadot R, Vanegas Arroyave N, Dang H, Anand A, Najera RA, Taneff LY, Bellows S, Tarakad A, Jankovic J, Horn A, Shofty B, Viswanathan A, Sheth SA (2022). Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease. J Neurosurg, 1-12. ()
    20. Das A, Myers J, Mathura R, Shofty B, Metzger BA, Bijanki K, Wu C, Jacobs J, Sheth SA (2022). Spontaneous neuronal oscillations in the human insula are hierarchically organized traveling waves. Elife, 11. ()
    21. Anand A, Magnotti JF, Smith DN, Gadot R, Najera RA, Hegazy MIR, Gavvala JR, Shofty B, Sheth SA (2022). Predictive value of magnetoencephalography in guiding the intracranial implant strategy for intractable epilepsy. J Neurosurg, 1-11. ()
    22. Shofty B, Gonen T, Bergmann E, Mayseless N, Korn A, Shamay-Tsoory S, Grossman R, Jalon I, Kahn I, Ram Z (2022). The default network is causally linked to creative thinking. Mol Psychiatry, 27(3), 1848-1854. ()
    23. Haim O, Abramov S, Shofty B, Fanizzi C, DiMeco F, Avisdris N, Ram Z, Artzi M, Grossman R (2022). Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases. J Neurooncol, 157(1), 63-69. ()
    24. Shofty B, Bergman L, Berger A, Aizenstein O, Ben-Valid S, Gurovich D, Tankus A, Attias M, Fahoum F, Strauss I (2021). Adopting MR-guided stereotactic laser ablations for epileptic lesions: initial clinical experience and lessons learned. Acta Neurochir (Wien), 163(10), 2797-2803. ()
    25. Shimony N, Popovits N, Shofty B, Abergel A, Ram Z, Grossman R (2021). Endoscopic transsphenoidal surgery reduces the need for re-operation compared to the microscopic approach in pituitary macroadenomas. Eur J Surg Oncol, 47(6), 1352-1356. ()
    26. Roth J, Jonas Kimchi T, Shofty B, Agur A, Ben-Sira L, Constantini S (2021). The Role of 3D Reconstruction of the Skull in Patients with Suspected Shunt Malfunction. Pediatr Neurosurg, 56(2), 110-115. ()
    27. Grossman R, Haim O, Abramov S, Shofty B, Artzi M (2021). Differentiating Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Brain Metastases Based on MRI Using Efficientnet and Transfer Learning Approach. Technol Cancer Res Treat, 20, 15330338211004919. ()
    28. Karas PJ, Giridharan N, Treiber JM, Prablek MA, Khan AB, Shofty B, Krishnan V, Chu J, Van Ness PC, Maheshwari A, Haneef Z, Gavvala JR, Sheth SA (2020). Accuracy and Workflow Improvements for Responsive Neurostimulation Hippocampal Depth Electrode Placement Using Robotic Stereotaxy. Front Neurol, 11, 590825. ()
    29. Shofty B, Haim O, Costa M, Kashanian A, Shtrozberg S, Ram Z, Grossman R (2020). Impact of repeated operations for progressive low-grade gliomas. Eur J Surg Oncol, 46(12), 2331-2337. ()
    30. Sapir Y, Korn A, Bitan-Talmor Y, Vendrov I, Berger A, Shofty B, Zegerman A, Strauss I (2020). Intraoperative Neurophysiology for Optimization of Percutaneous Spinothalamic Cordotomy for Intractable Cancer Pain. Oper Neurosurg (Hagerstown), 19(6), E566-E572. ()
    31. Artzi M, Gershov S, Ben-Sira L, Roth J, Kozyrev D, Shofty B, Gazit T, Halag-Milo T, Constantini S, Ben Bashat D (2020). Automatic segmentation, classification, and follow-up of optic pathway gliomas using deep learning and fuzzy c-means clustering based on MRI. Med Phys, 47(11), 5693-5701. ()
    32. Asleh J, Shofty B, Cohen N, Kavushansky A, Lpez-Jurez A, Constantini S, Ratner N, Kahn I (2020). Brain-wide structural and functional disruption in mice with oligodendrocyte-specific NF1 deletion is rescued by inhibition of nitric oxide synthase. Proc Natl Acad Sci U S A, 117(36), 22506-22513. ()
    33. Shofty B, Artzi M, Shtrozberg S, Fanizzi C, DiMeco F, Haim O, Peleg Hason S, Ram Z, Bashat DB, Grossman R (2020). Virtual biopsy using MRI radiomics for prediction of BRAF status in melanoma brain metastasis. Sci Rep, 10(1), 6623. ()
    34. Shofty B, Mauda-Havakuk M, Ben-Sira L, Bokstein F, Lidar Z, Salame K, Korn A, Constantini S (2019). Surgical Management of "Kissing" Spinal Plexiform Neurofibromas in Neurofibromatosis Type 1 Patients. World Neurosurg, 134, e1143-e1147. ()
    35. Shofty B, Richetta C, Haim O, Kashanian A, Gurevich A, Grossman R (2019). 5-ALA-assisted stereotactic brain tumor biopsy improve diagnostic yield. Eur J Surg Oncol, 45(12), 2375-2378. ()
    36. Shofty B, Bergmann E, Zur G, Asleh J, Bosak N, Kavushansky A, Castellanos FX, Ben-Sira L, Packer RJ, Vezina GL, Constantini S, Acosta MT, Kahn I (2019). Autism-associated Nf1 deficiency disrupts corticocortical and corticostriatal functional connectivity in human and mouse. Neurobiol Dis, 130, 104479. ()
    37. Richetta C, Shofty B, Gurevich A, Grossman R (2019). Valve Failure in Ventriculoperitoneal Shunts of Neuro-Oncologic Patients: A Historical Cohort Study. World Neurosurg, 128, e329-e333. ()
    38. van Baarsen K, Roth J, Serova N, Packer RJ, Shofty B, Thomale UW, Cinalli G, Toledano H, Michowiz S, Constantini S (2017). Optic pathway-hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature. J Neurosurg, 129(6), 1407-1415. ()
    39. Shofty B, Artzi M, Ben Bashat D, Liberman G, Haim O, Kashanian A, Bokstein F, Blumenthal DT, Ram Z, Shahar T (2017). MRI radiomics analysis of molecular alterations in low-grade gliomas. Int J Comput Assist Radiol Surg, 13(4), 563-571. ()
    40. Barzilai O, Ben Moshe S, Sitt R, Sela G, Shofty B, Ram Z (2018). Improvement in cognitive function after surgery for low-grade glioma. J Neurosurg, 1-9. ()
    41. Gonen L, Nov E, Shimony N, Shofty B, Margalit N (2017). Sphenoorbital meningioma: surgical series and design of an intraoperative management algorithm. Neurosurg Rev, 41(1), 291-301. ()
    42. Shofty B, Ben-Sira L, Kesler A, Jallo G, Groves ML, Iyer RR, Lassaletta A, Tabori U, Bouffet E, Thomale UW, Herniz Driever P, Constantini S, Isolated Optic Nerve Abnormalities IONA Collaboration (2017). Isolated optic nerve gliomas: a multicenter historical cohort study. J Neurosurg Pediatr, 20(6), 549-555. ()
    43. Mauda-Havakuk M, Shofty B, Ben-Shachar S, Ben-Sira L, Constantini S, Bokstein F (2017). Spinal and Paraspinal Plexiform Neurofibromas in Patients with Neurofibromatosis Type 1: A Novel Scoring System for Radiological-Clinical Correlation. AJNR Am J Neuroradiol, 38(10), 1869-1875. ()
    44. Shimony N, Shofty B, Harosh CB, Sitt R, Ram Z, Grossman R (2016). Surgical Resection of Cerebral Metastases Leads to Faster Resolution of Peritumoral Edema than Stereotactic Radiosurgery: A Volumetric Analysis. Ann Surg Oncol, 24(5), 1392-1398. ()
    45. Shimony N, Shofty B, Ram Z, Grossman R (2016). Perioperative Risk Assessment of Patients with Gliomatosis Cerebri. World Neurosurg, 98, 334-338. ()
    46. Shimony N, Gonen L, Shofty B, Abergel A, Fliss DM, Margalit N (2016). Surgical resection of skull-base chordomas: experience in case selection for surgical approach according to anatomical compartments and review of the literature. Acta Neurochir (Wien).
    47. Neuberger A, Shofty B, Bishop B, Naffaa ME, Binawi T, Babich T, Rappaport ZH, Zaaroor M, Sviri G, Yahav D, Paul M (2016). Risk factors associated with death or neurological deterioration among patients with Gram-negative postneurosurgical meningitis. Clin Microbiol Infect, 22(6), 573.e1-4. ()
    48. Shofty B, Neuberger A, Naffaa ME, Binawi T, Babitch T, Rappaport ZH, Zaaroor M, Sviri G, Paul M (2015). Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study. Clin Microbiol Infect, 22(1), 66-70. ()
    49. Shofty B, Mauda-Havakuk M, Weizman L, Constantini S, Ben-Bashat D, Dvir R, Pratt LT, Joskowicz L, Kesler A, Yalon M, Ravid L, Ben-Sira L (2015). The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study. Pediatr Blood Cancer, 62(8), 1353-9. ()
    50. Pratt L, Helfer D, Weizman L, Shofty B, Constantini S, Joskowicz L, Ben Bashat D, Ben-Sira L (2015). Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice. Acta Neurochir (Wien), 157(5), 855-61. ()
    51. Weizman L, Helfer D, Ben Bashat D, Pratt LT, Joskowicz L, Constantini S, Shofty B, Ben Sira L (2013). PNist: interactive volumetric measurements of plexiform neurofibromas in MRI scans. Int J Comput Assist Radiol Surg, 9(4), 683-93. ()
    52. Ram ST, Neuberger A, Thapa LJ, Vir Singh RP, Shofty B, Schwartz E (2014). Japanese encephalitis among patients with acute encephalitic syndrome admitted to a tertiary hospital in Chitwan, Nepal--a prospective observational study. PLoS One, 9(6), e99999. ()
    53. Weizman L, Sira LB, Joskowicz L, Rubin DL, Yeom KW, Constantini S, Shofty B, Bashat DB (2014). Semiautomatic segmentation and follow-up of multicomponent low-grade tumors in longitudinal brain MRI studies. Med Phys, 41(5), 052303. ()
    54. Shofty B, Constantini S, Bokstein F, Ram Z, Ben-Sira L, Freedman S, Vainer G, Kesler A (2013). Optic pathway gliomas in adults. Neurosurgery, 74(3), 273-9; discussion 279-80. ()
    55. Shofty B, Ben-Sira L, Constantini S, Freedman S, Kesler A (2011). Optic nerve sheath diameter on MR imaging: establishment of norms and comparison of pediatric patients with idiopathic intracranial hypertension with healthy controls. AJNR Am J Neuroradiol, 33(2), 366-9. ()
    56. Weizman L, Ben Sira L, Joskowicz L, Constantini S, Precel R, Shofty B, Ben Bashat D (2011). Automatic segmentation, internal classification, and follow-up of optic pathway gliomas in MRI. Med Image Anal, 16(1), 177-88. ()
    57. Weizman L, Ben-Sira L, Joskowicz L, Aizenstein O, Shofty B, Constantini S, Ben-Bashat D (2013). Prediction of brain MR scans in longitudinal tumor follow-up studies. 15(Pt 2), 179-87. ()
    58. Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, Toledano H, Constantini S, Kesler A (2011). Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer, 57(3), 481-5. ()
    59. Shofty B, Weizman L, Joskowicz L, Constantini S, Kesler A, Ben-Bashat D, Yalon M, Dvir R, Freedman S, Roth J, Ben-Sira L (2011). MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm. Childs Nerv Syst, 27(8), 1265-72. ()

    Review

    1. Shofty B, Gadot R, Provenza N, Storch EA, Goodman WK, Sheth SA (2022). Neurosurgical Approaches for Treatment-Resistant Obsessive-Compulsive Disorder. [Review]. Psychiatr Clin North Am, 46(1), 121-132. ()
    2. Gadot R, Najera R, Hirani S, Anand A, Storch E, Goodman WK, Shofty B, Sheth SA (2022). Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. [Review]. J Neurol Neurosurg Psychiatry. ()
    3. Najera RA, Gregory ST, Shofty B, Anand A, Gadot R, Youngerman BE, Storch EA, Goodman WK, Sheth SA (2022). Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder. [Review]. J Neurosurg, 1-11. ()
    4. Allam AK, Larkin Michael MB, Shofty B, Viswanathan A (2022). Ablation Procedures. [Review]. Neurosurg Clin N Am, 33(3), 339-344. ()
    5. Gadot R, Korst G, Shofty B, Gavvala JR, Sheth SA (2022). Thalamic stereoelectroencephalography in epilepsy surgery: a scoping literature review. [Review]. J Neurosurg, 1-16. ()
    6. Shofty B, Ben Sira L, Constantini S (2020). Neurofibromatosis 1-associated optic pathway gliomas. [Review]. Childs Nerv Syst, 36(10), 2351-2361. ()
    7. Shofty B, Barzilai O, Khashan M, Lidar Z, Constantini S (2020). Spinal manifestations of Neurofibromatosis type 1. [Review]. Childs Nerv Syst, 36(10), 2401-2408. ()
    8. Shimony N, Gonen L, Shofty B, Abergel A, Fliss DM, Margalit N (2016). Surgical resection of skull-base chordomas: experience in case selection for surgical approach according to anatomical compartments and review of the literature. [Review]. Acta Neurochir (Wien), 159(10), 1835-1845. ()
    9. Hussein K, Bitterman R, Shofty B, Paul M, Neuberger A (2017). Management of post-neurosurgical meningitis: narrative review. [Review]. Clin Microbiol Infect, 23(9), 621-628. ()
    10. Shofty B, Constantini S, Ben-Shachar S (2015). Advances in Molecular Diagnosis of Neurofibromatosis Type 1. [Review]. Semin Pediatr Neurol, 22(4), 234-9. ()
    11. Shofty B, Ben-Sira L, Kesler A, Constantini S (2014). Optic pathway gliomas. [Review]. Adv Tech Stand Neurosurg, 42, 123-46. ()
    12. Shofty B, Constantini S, Freedman S, Ben-Sira L, Kesler A (2011). [Optic pathway gliomas--current position and future directions]. [Review]. Harefuah, 149(11), 721-5, 748. ()

    Book Chapter

    1. Shofty B, Ben-Sira L, Toledano-Alhadef H, Bokstein F, Constantini S (2018). Neurofibromatosis type I. In Jallo GI, Kothbauer K, Recinos VMR (Eds.), Handbook of Pediatric Neurosurgery. Thieme.
    2. Shofty B, Barzilai O, Lidar Z, Hwang E, Constantini S (2017). Pediatric Intradural Spinal Cord Tumors. In Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman AL, Pearl PL, Shevell M (Eds.), Swaiman’s Pediatric Neurology: Principles and Practice (6th Edition). Elsevier.
    3. Shofty B, Ben-Sira L, Kesler A, Constantini S (2014). Optic Pathway Gliomas. In Albright AL, Pollack IF, Adelson PD (Eds.), Principles and Practice of Pediatric Neurosurgery (3rd Edition). Thieme.
    4. Shofty B, Ben-Sira L, Kesler A, Constantini S (2013). Optic Pathway Gliomas. In Pickard JD, Rocco C, Dolenc VV, Fahlbusch R, Lobo Antunes J, Sindou M, Tribolet N, Tulleken CAF, Vapalahti M (Eds.), Advances and Technical Standards in Neurosurgery ((NEUROSURGERY, volume 29)). Springer.
    5. Shofty B, Korn A, Lidar Z, Constantini S (2012). Intradural Spinal Cord Tumors. In Packer RJ, Schiff D (Eds.), Neurology in Practice: Neuro-Oncology (1st Edition). Wiley-Blackwell.

    Commentary

    1. Shofty B, Grossman R (2015). Treatment Options for Chronic Subdural Hematoma. World Neurosurg, 87, 529-30. ()

    Case Report

    1. Anand A, Gavvala JR, Mathura R, Najera RA, Gadot R, Shofty B, Sheth SA (2022). Elimination of anxiety after laser interstitial thermal ablation of the dominant cingulate gyrus for epilepsy. Surg Neurol Int, 13, 178. ()
    2. Gadot R, Shofty B, Najera RA, Anand A, Banks G, Khan AB, LoPresti MA, Vanegas Arroyave N, Sheth SA (2021). Case Report: Dual Target Deep Brain Stimulation With Externalized Programming for Post-traumatic Complex Movement Disorder. Front Neurosci, 15, 774073. ()
    3. Shofty B, Roth J, Ben-Sira L, Brotchi J, Korn A, Constantini S (2012). Massive hematomyelia following intramedullary spinal cord tumor surgery. Acta Neurochir (Wien), 154(4), 751-2. ()

    Letter

    1. Findlay MC, Campbell JM, Rahimpour S, Shofty B (2024). Incidental Brain Lesions in Parkinson Disease: High Prevalence, Minimal Impact on DBS Outcomes. [Letter to the editor]. World Neurosurg. ()
    2. Dang HQ, Provenza NR, Banks GP, Giridharan N, Avendano-Ortega M, McKay SA, Devara E, Shofty B, Storch EA, Sheth SA, Goodman WK (2023). Attenuating side effects of deep brain stimulation in the bed nucleus of the stria terminalis for obsessive compulsive disorder using current-steering strategies. [Letter to the editor]. Brain Stimul, 16(2), 650-652. ()
    3. Najera RA, Provenza N, Dang H, Katlowitz KA, Hertz A, Reddy S, Shofty B, Bellows ST, Storch EA, Goodman WK, Sheth SA (2023). Dual-Target Deep Brain Stimulation for Obsessive-Compulsive Disorder and Tourette Syndrome. [Letter to the editor]. Biol Psychiatry, 93(11), e53-e55. ()

    Video/Film/CD/Web/Podcast

    1. Shofty B, Mathura RK, Provenza NR, Vogt GS, Storch EA, Goodman WK, Sheth SA (2021). DBS for Severe, treatment resistant obsessive-compulsive disorder [Web]. CNS Nexus. Available: https://www.cns.org/nexus/case/detail/dbs-severe- treatment-resistant-obsessive-compulsiv.
  • Clinical Trials